Protein kinase N1 deficiency results in upregulation of cerebral energy metabolism and is highly protective in in vivo and in vitro stroke models

This is the first study to comprehensively demonstrate an essential and unique role of PKN1 in cerebral energy metabolism, regulating glycolysis and mitochondrial pyruvate-induced respiration. We further uncovered a highly protective phenotype of Pkn1 deficiency in both, in vitro and in vivo stroke models, validating inhibition of PKN1 as a promising new therapeutic target for the development of novel stroke therapies.

Authors

Institutions

Publication Details

Journal
Metabolism
Published
2024-09-26
DOI
https://doi.org/10.1016/j.metabol.2024.156039
Citations
3
Primary Topic
Cancer, Hypoxia, and Metabolism
Type
article
Field-Weighted Citation Impact
0.86

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Protein kinase N1 deficiency results in upregulation of cerebral energy metabolism and is highly protective in in vivo and in vitro stroke models

Anne Krogsdam, Cyrille Orset, Bettina Sarg, Stephanie zur Nedden et al.
3 citations
Metabolism
Cancer, Hypoxia, and Metabolism
0.86
article

Protein kinase N1 deficiency results in upregulation of cerebral energy metabolism and is highly protective in in vivo and in vitro stroke models

Anne Krogsdam, Cyrille Orset, Bettina Sarg, Stephanie zur Nedden, Angus J.M. Cameron, Ira Skvortsova, Gottfried Baier, Dragana Savic, Herbert Oberacher, Sandro Carollo, Madlen Hotze, Motahareh Solina Safari, Zlatko Trajanoski, Marcel Kwiatkowski, Klaus Faserl, Carolin Garmsiri, Louisa Kuenkel, Florian Ostermaier, Dominik Zlotek, Benoît Haelewyn, L. Láng, Dido Weber, Tom Freret
article en
3 citations

Abstract

This is the first study to comprehensively demonstrate an essential and unique role of PKN1 in cerebral energy metabolism, regulating glycolysis and mitochondrial pyruvate-induced respiration. We further uncovered a highly protective phenotype of Pkn1 deficiency in both, in vitro and in vivo stroke models, validating inhibition of PKN1 as a promising new therapeutic target for the development of novel stroke therapies.

MetabolismVol. 161
Innsbruck Medical University (AT), Inserm (FR), Queen Mary University of London (GB), Universität Innsbruck (AT), Tyrolean Cancer Research Institute (AT), Normandie Université (FR), Cyceron (FR), Université de Caen Normandie (FR)
Austrian Science Fund
Affordable and clean energy
Openalex Percentile: Top 25%
Cancer, Hypoxia, and Metabolism
0.86
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.